Inventor · disambiguated record
James F. Holland
Also filed as: HOLLAND JAMES · HOLLAND JAMES F
11 granted patents·153 citations·filing 1981–2006
90Inventor score
Top patents by PatentIndex Score
11 records- 0188US7510707B2PAR, a novel marker gene for breast and prostate cancersNEW YORK UNIVERSITY MT SINAI S·Filed 2002·Granted Mar 31, 2009·87 cites·25 claims
- 0285US6590123B2Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the sameSINAI SCHOOL MEDICINE·Filed 2001·Granted Jul 8, 2003·24 cites·3 claims
- 0381US8664272B2Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemiaREDDY E PREMKUMAR·Filed 2006·Granted Mar 4, 2014·9 cites·30 claims
- 0477US8106033B2Composition and methods for the treatment of proliferative diseasesREDDY E PREMKUMAR·Filed 2006·Granted Jan 31, 2012·3 cites·18 claims
- 0558US6294695B1Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the sameSINAI SCHOOL MEDICINE·Filed 1999·Granted Sep 25, 2001·7 cites·10 claims
- 0640US5686247ADetection of mammary tumor virus env gene-like sequences in human breast cancerSINAI SCHOOL MEDICINE·Filed 1995·Granted Nov 11, 1997·9 cites·14 claims
- 0739US4455379ALeukocyte adherence inhibition assaySINAI SCHOOL MEDICINE·Filed 1981·Granted Jun 19, 1984·8 cites·9 claims
- 0832US5795740APituitary differentiation factor and methods of use thereofSINAI SCHOOL MEDICINE·Filed 1997·Granted Aug 18, 1998·1 cites·15 claims
- 0931US4666834ALeukocyte adherence inhibition assaySINAI SCHOOL MEDICINE·Filed 1984·Granted May 19, 1987·3 cites·1 claims
- 1028US6040146ADetection of mammary tumor virus-like sequences in human breast cancerSINAI SCHOOL MEDICINE·Filed 1996·Granted Mar 21, 2000·2 cites·12 claims
- 1127US5888817APituitary differentiaton factor and methods of use thereofSINAI SCHOOL MEDICINE·Filed 1997·Granted Mar 30, 1999·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when James F. Holland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →